You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 246 No. 22, December 4, 1981 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (18)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Step-Down Therapy in Hypertension

Importance in Long-term Management

Frank A. Finnerty, Jr, MD

JAMA. 1981;246(22):2593-2596.


Abstract

To determine the minimum amount of therapy needed to control arterial pressure, the amount of one drug was reduced, then use of one or more drugs was discontinued after the diastolic pressure had been lower than 90 mm Hg for six months in 51 hypertensive patients. By six months, one drug had been eliminated in 38 patients, and the dose of another had been decreased in 49 patients. By 12 months, stepping up therapy was necessary in 13 patients; thus, one drug therapy had been eliminated in only 27 patients, and the dose was decreased in another 43 patients. No further therapeutic changes were necessary during the next six months. Originally, 161 complaints of side effects were noted. After step-down therapy, 18% of the side effects were reported unchanged, 26% were significantly decreased, and 56% were completely absent.

(JAMA 1981;246:2593-2596)



Author Affiliations

From the Department of Medicine, George Washington University Medical School, and The Hypertension Center of Washington, DC.


Footnotes

Reprint requests to The Hypertension Center of Washington, DC, 1341 Pennsylvania Ave SE, Washington, DC 20003 (Dr Finnerty).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Comparison of agreement between different measures of blood pressure in primary care and daytime ambulatory blood pressure
Little et al.
BMJ 2002;325:254-254.
ABSTRACT | FULL TEXT  

Effect of Administration and Withdrawal of Doxazosin on Ambulatory Blood Pressure in Patients with Essential Hypertension
Takata et al.
ANGIOLOGY 1995;46:11-18.
ABSTRACT  

Doxazosin Withdrawal and Ambulatory Blood Pressure Monitoring in Normotensive Subjects
Takata et al.
ANGIOLOGY 1994;45:17-23.
ABSTRACT  

Remission of Hypertension: The 'Natural' History of Blood Pressure Treatment in the Framingham Study
Dannenberg and Kannel
JAMA 1987;257:1477-1483.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.